SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001354488-16-005752
Filing Date
2016-01-04
Accepted
2016-01-04 17:15:55
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT issuerdirect_section16.html 4  
1 PRIMARY DOCUMENT issuerdirect_section16.xml 4 2802
  Complete submission text file 0001354488-16-005752.txt   4490
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARQULE, INC. 1 WALL STREET, 6TH FLOOR BURLINGTON MA 01803
Business Address
BARABE TIMOTHY C (Reporting) CIK: 0001237409 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33004 | Film No.: 161319138